ISHINE Intern 2024 -- Global Patient Safety

Ironwood Pharmaceuticals

Feb 2, 2024

Applications are closed

Internship
Full-time
Off-cycle Internship
Healthcare
Boston

Requirements

A pharmacy student who has completed a minimum of 1 year of professional pharmacy courses would be preferred.
Strong skills in powerpoint.

Responsibilities

Training on Adverse Event, Special Situation, and Product Quality Complaints Reporting Policy: The intern will be tasked with developing a comprehensive training program focused on the corporate policy. This training will ensure that all Ironwood employees are well-versed in the procedures and protocols associated with reporting requirements. The presentation is intended to be a supplement to anyone assigned to the corporate policy IPI-BCP-002.
PowerPoint Presentation on Safety Guidances: The intern will work on developing an overview PowerPoint presentation, which will serve as a resource for cross-functional colleagues. The presentation will be tailored for cross-functional colleagues' onboarding and provide clear responsibilities and guidance for frequent pharmacovigilance deliverables that occur between pharmacovigilance and cross-functional colleagues.
Mini-Drug Development Course: The intern will be responsible for creating a comprehensive drug development course tailored for our PharmD APPE students and Fellows. This initiative aims to enhance the understanding of drug development processes and create awareness of the pharmaceutical industry's vital aspects.
PowerPoint Presentation(s) on Aggregate Safety Reports and Risk Management Plans: The intern will contribute to the creation of PowerPoint presentations that cover specific safety documents such as the Developmental Safety Update Report (DSUR), Periodic-Benefit Risk Evaluation Report (PBRER), and Risk Management Plan (RMP). Each presentation will be designed for cross-functional team members to facilitate effective collaboration on these important regulatory documents. The presentation(s) will be a deeper dive into specific safety reports intended to be provided at the beginning of the report authoring. Depending on the intern’s progress on the prior presentations, these presentations could be expanded during their internship.
Training on Adverse Event, Special Situation, and Product Quality Complaints Reporting Policy: The intern will be tasked with developing a comprehensive training program focused on the corporate policy. This training will ensure that all Ironwood employees are well-versed in the procedures and protocols associated with reporting requirements. The presentation is intended to be a supplement to anyone assigned to the corporate policy IPI-BCP-002.
PowerPoint Presentation on Safety Guidances: The intern will work on developing an overview PowerPoint presentation, which will serve as a resource for cross-functional colleagues. The presentation will be tailored for cross-functional colleagues' onboarding and provide clear responsibilities and guidance for frequent pharmacovigilance deliverables that occur between pharmacovigilance and cross-functional colleagues.
Mini-Drug Development Course: The intern will be responsible for creating a comprehensive drug development course tailored for our PharmD APPE students and Fellows. This initiative aims to enhance the understanding of drug development processes and create awareness of the pharmaceutical industry's vital aspects.
PowerPoint Presentation(s) on Aggregate Safety Reports and Risk Management Plans: The intern will contribute to the creation of PowerPoint presentations that cover specific safety documents such as the Developmental Safety Update Report (DSUR), Periodic-Benefit Risk Evaluation Report (PBRER), and Risk Management Plan (RMP). Each presentation will be designed for cross-functional team members to facilitate effective collaboration on these important regulatory documents. The presentation(s) will be a deeper dive into specific safety reports intended to be provided at the beginning of the report authoring. Depending on the intern’s progress on the prior presentations, these presentations could be expanded during their internship

Ironwood Pharmaceuticals

Ironwood is on a mission to advance treatment of gastrointestinal diseases & redefine the standard of care for patients

Science & Healthcare

Industry

201-500

Employees

1998

Founded Year

Mission & Purpose

At Ironwood Pharmaceuticals, we are committed to advancing the treatment of GI diseases and redefining the standard of care for GI patients. As a pioneer and champion in the development of a market-leading therapy for IBS-C and CIC, we are singularly focused on advancing the treatment of GI diseases and continue to challenge what has been done before to shape what the future holds. So, we named ourselves after the Ironwood tree, which can live for thousands of years in the harshest desert, creating a shaded microclimate in which life thrives. Iron, like science, is undeniable and strong. Wood, like artistry and humanity, is flexible, resilient and versatile. The two words together represent our passion for making a positive impact on the health – and lives- of GI patients, their families and communities. Our core values: •Transform Patient Lives: Leverage our insights, capabilities, and expertise to see the most critical patient needs. •Innovate Meaningfully: Think boldly, experiment proactively, and take initiative to create new possibilities in the GI world. •Challenge and Collaborate: Encourage different opinions and points of views in decision-making. •Practice Humanity: Recognize that our people are the cornerstone of Ironwood. •Own The Outcome: Honor our commitments to our patients, stakeholders, and one another by upholding a performance-driven culture.